Skip to main content
Erschienen in: Current Dermatology Reports 4/2014

01.12.2014 | Pediatrics (R Sidbury, Section Editor)

Pediatric Dermatology Clinical-Pathologic Cases: A Spectrum of Purpuric Disorders of Childhood

verfasst von: Keith W Morley, Jennifer Huang, Birgitta A.R. Schmidt

Erschienen in: Current Dermatology Reports | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

In the following sections, we will present three recent cases of pediatric purpura encountered on the inpatient dermatology consult service from a tertiary pediatric hospital. In all cases, the final diagnoses were established with dermatopathologic-clinical correlation and special stains.
Literatur
1.
Zurück zum Zitat Maguiness S et al. Bullous Henoch-Schonlein purpura in children: a report of 6 cases and review of the literature. Clin Pediatr. 2010;49:1033–7.CrossRef Maguiness S et al. Bullous Henoch-Schonlein purpura in children: a report of 6 cases and review of the literature. Clin Pediatr. 2010;49:1033–7.CrossRef
3.
Zurück zum Zitat Saulsbury FT. Henoch-Schonlein purpura in children—report of 100 patients and review of the literature. Medicine. 1999;78:395–409.PubMedCrossRef Saulsbury FT. Henoch-Schonlein purpura in children—report of 100 patients and review of the literature. Medicine. 1999;78:395–409.PubMedCrossRef
4.
Zurück zum Zitat Tizard EJ, Hamilton-Ayres MJ. Henoch Schonlein purpura. Arch Dis Chil Educ Prac Ed. 2008;93:1–8.CrossRef Tizard EJ, Hamilton-Ayres MJ. Henoch Schonlein purpura. Arch Dis Chil Educ Prac Ed. 2008;93:1–8.CrossRef
5.•
Zurück zum Zitat Pohl M. Henoch-Schonlein purpura nephritis. Pediatr Nephrol. 2014. [Epub ahead of print]. Comprehensive review of the etiologies, prognoses, and treatments of HSP induced renal disease. Pohl M. Henoch-Schonlein purpura nephritis. Pediatr Nephrol. 2014. [Epub ahead of print]. Comprehensive review of the etiologies, prognoses, and treatments of HSP induced renal disease.
7.
Zurück zum Zitat Shenoy M, Ognjanovic MV, Coulthard MG. Treating severe Henoch-Schonlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol. 2007;22:1167–71.PubMedCrossRef Shenoy M, Ognjanovic MV, Coulthard MG. Treating severe Henoch-Schonlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol. 2007;22:1167–71.PubMedCrossRef
8.•
Zurück zum Zitat Muhammed M et al. Fusarium infection: report of 26 cases and review of 97 cases from the literature. Medicine. 2013;92(6):305–16. Largest case series to date describing different variations and manifestations of Fusarium infection.PubMedCrossRef Muhammed M et al. Fusarium infection: report of 26 cases and review of 97 cases from the literature. Medicine. 2013;92(6):305–16. Largest case series to date describing different variations and manifestations of Fusarium infection.PubMedCrossRef
9.
Zurück zum Zitat Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis. 2002;35:909–20.PubMedCrossRef Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis. 2002;35:909–20.PubMedCrossRef
11.
Zurück zum Zitat Vinh DC et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood. 2010;115:1519–29.PubMedCentralPubMedCrossRef Vinh DC et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood. 2010;115:1519–29.PubMedCentralPubMedCrossRef
12.••
Zurück zum Zitat Hsu AP et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653–5. The initial paper to identify the GATA2 as the causative mutation underlying MonoMAC syndrome.PubMedCentralPubMedCrossRef Hsu AP et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653–5. The initial paper to identify the GATA2 as the causative mutation underlying MonoMAC syndrome.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Camargo JF et al. MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. Clin Infect Dis. 2013;57:697–9.PubMedCentralPubMedCrossRef Camargo JF et al. MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. Clin Infect Dis. 2013;57:697–9.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Gee SN et al. Rapidly fatal multiorgan Langerhans cell histiocytosis in a neonate. Pediatr Derm. 2013;30(5):e85–6.CrossRef Gee SN et al. Rapidly fatal multiorgan Langerhans cell histiocytosis in a neonate. Pediatr Derm. 2013;30(5):e85–6.CrossRef
15.
16.
Zurück zum Zitat Stein S et al. Langerhans cell histiocytosis presenting in the neonatal period. Arch Pediatr Adolesc Med. 2001;155:778–83.PubMedCrossRef Stein S et al. Langerhans cell histiocytosis presenting in the neonatal period. Arch Pediatr Adolesc Med. 2001;155:778–83.PubMedCrossRef
17.
Zurück zum Zitat Jaffe R. Is there a role for histopathology in predicting the clinical outcome in congenital and infant Langerhans cell disease? Pediatr Blood Cancer. 2009;53:924–5.PubMedCrossRef Jaffe R. Is there a role for histopathology in predicting the clinical outcome in congenital and infant Langerhans cell disease? Pediatr Blood Cancer. 2009;53:924–5.PubMedCrossRef
Metadaten
Titel
Pediatric Dermatology Clinical-Pathologic Cases: A Spectrum of Purpuric Disorders of Childhood
verfasst von
Keith W Morley
Jennifer Huang
Birgitta A.R. Schmidt
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Current Dermatology Reports / Ausgabe 4/2014
Elektronische ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-014-0087-9

Weitere Artikel der Ausgabe 4/2014

Current Dermatology Reports 4/2014 Zur Ausgabe

Pediatrics (R Sidbury, Section Editor)

What’s New in Pediatric Dermatology

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.